MP1032
Tracked across 1 events · 6 articles · First seen May 26, 2026 · Last active May 26, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: MP1032>>> is the lead compound of MetrioPharm AG>>> for inflammatory and infectious diseases, and its development strategy will be further supported by the expertise of Jürgen Braun>>>.
May 26, 2026 · 6 articles
ERGEN INTELLIGENCE
Track MP1032 live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard